Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1980 2
1981 2
1982 3
1983 1
1984 1
1985 6
1986 2
1987 10
1988 11
1989 9
1990 20
1991 12
1992 16
1993 15
1994 12
1995 25
1996 23
1997 25
1998 28
1999 30
2000 27
2001 20
2002 29
2003 34
2004 24
2005 22
2006 38
2007 22
2008 30
2009 48
2010 38
2011 53
2012 54
2013 67
2014 72
2015 81
2016 66
2017 81
2018 102
2019 90
2020 79
2021 88
2022 76
2023 81
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

1,434 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC; CRISP Consortium. Rossetti S, et al. J Am Soc Nephrol. 2007 Jul;18(7):2143-60. doi: 10.1681/ASN.2006121387. Epub 2007 Jun 20. J Am Soc Nephrol. 2007. PMID: 17582161
Mutation-based molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) is complicated by genetic and allelic heterogeneity, large multi-exon genes, duplication of PKD1, and a high level of unclassified variants (UCV). ...Definite mutatio …
Mutation-based molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) is complicated by genetic …
The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
Cornec-Le Gall E, Audrézet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y. Cornec-Le Gall E, et al. J Am Soc Nephrol. 2016 Mar;27(3):942-51. doi: 10.1681/ASN.2015010016. Epub 2015 Jul 6. J Am Soc Nephrol. 2016. PMID: 26150605 Free PMC article.
The course of autosomal dominant polycystic kidney disease (ADPKD) varies among individuals, with some reaching ESRD before 40 years of age and others never requiring RRT. ...This new prognostic score accurately predicts renal outcomes in patien …
The course of autosomal dominant polycystic kidney disease (ADPKD) varies among individuals, with some reaching ESRD be …
Polycystic Kidney Disease and Renal Fibrosis.
Xue C, Mei CL. Xue C, et al. Adv Exp Med Biol. 2019;1165:81-100. doi: 10.1007/978-981-13-8871-2_5. Adv Exp Med Biol. 2019. PMID: 31399962 Review.
Polycystic kidney disease (PKD) is a common genetic disorder characterized by formations of numerous cysts in kidneys and most caused by PKD1 or PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD). The interstitial infl
Polycystic kidney disease (PKD) is a common genetic disorder characterized by formations of numerous cysts in kidneys a
Type of PKD1 mutation influences renal outcome in ADPKD.
Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y. Cornec-Le Gall E, et al. J Am Soc Nephrol. 2013 May;24(6):1006-13. doi: 10.1681/ASN.2012070650. Epub 2013 Feb 21. J Am Soc Nephrol. 2013. PMID: 23431072 Free PMC article.
Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, as well as phenotypic variability. ...The median age at onset of ESRD was 55 years for carriers of a truncating mutation and 67 years for car …
Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, a …
Renoprotective Effects of Metformin.
De Broe ME, Kajbaf F, Lalau JD. De Broe ME, et al. Nephron. 2018;138(4):261-274. doi: 10.1159/000481951. Epub 2017 Dec 14. Nephron. 2018. PMID: 29241197 Free article. Review.
METHODS: A literature search was performed in PUBMED, ScienceDirect, between January 1957 and March 2017 using the following keywords: "metformin," "nephroprotection," "renoprotection," "survival," "renal failure," "chronic kidney diseases," "fibrosis," "polycystic kidn
METHODS: A literature search was performed in PUBMED, ScienceDirect, between January 1957 and March 2017 using the following keywords: "metf …
Tissue-engineered kidney disease models.
Desrochers TM, Palma E, Kaplan DL. Desrochers TM, et al. Adv Drug Deliv Rev. 2014 Apr;69-70:67-80. doi: 10.1016/j.addr.2013.12.002. Epub 2013 Dec 17. Adv Drug Deliv Rev. 2014. PMID: 24361391 Free PMC article. Review.
Historically these diseases have been studied with patient observation and screening, animal models, and two-dimensional cell culture. ...The cells and materials utilized to develop these models are discussed and tissue engineered models of polycystic kidney
Historically these diseases have been studied with patient observation and screening, animal models, and two-dimensional cell culture …
Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients.
Oh YK, Park HC, Ryu H, Kim YC, Oh KH. Oh YK, et al. Korean J Intern Med. 2021 Jul;36(4):767-779. doi: 10.3904/kjim.2021.176. Epub 2021 Jul 1. Korean J Intern Med. 2021. PMID: 34237823 Free PMC article. Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized by cyst growth in the kidneys, resulting in kidney enlargement and end-stage kidney disease. The polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized …
Genetics and Autosomal Dominant Polycystic Kidney Disease Progression.
Corradi V, Giuliani A, Gastaldon F, de Cal M, Mancini B, Montaldi A, Alghisi A, Capelli I, La Manna G, Ronco C. Corradi V, et al. Contrib Nephrol. 2017;190:117-123. doi: 10.1159/000468956. Epub 2017 May 23. Contrib Nephrol. 2017. PMID: 28535524 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, accounting for 10% of European patients on renal replacement therapy. ...In addition to having diagnostic role, the description of the genotype is even importan …
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, accounting for 10% o …
Apoptosis and autophagy in polycystic kidney disease (PKD).
Nowak KL, Edelstein CL. Nowak KL, et al. Cell Signal. 2020 Apr;68:109518. doi: 10.1016/j.cellsig.2019.109518. Epub 2019 Dec 24. Cell Signal. 2020. PMID: 31881325 Free PMC article. Review.
Apoptosis in the cystic epithelium is observed in most rodent models of polycystic kidney disease (PKD) and in human autosomal dominant PKD (ADPKD). ...
Apoptosis in the cystic epithelium is observed in most rodent models of polycystic kidney disease (PKD) and in h …
MRI in autosomal dominant polycystic kidney disease.
Zhang W, Blumenfeld JD, Prince MR. Zhang W, et al. J Magn Reson Imaging. 2019 Jul;50(1):41-51. doi: 10.1002/jmri.26627. Epub 2019 Jan 13. J Magn Reson Imaging. 2019. PMID: 30637853 Review.
Magnetic resonance imaging (MRI) is increasingly used in autosomal dominant polycystic kidney disease (ADPKD) for diagnosis, classification, assessment of disease progression and treatment response, and for identifying complications. ...We show how MRI-derive …
Magnetic resonance imaging (MRI) is increasingly used in autosomal dominant polycystic kidney disease (ADPKD) for diagn …
1,434 results